Global Heart Pump Device Market to Reach US$ 25.4 Billion by 2034: Rising Prevalence of Cardiovascular Diseases and Growing Geriatric Population | Future Market Insights Inc.
The heart pump device market continues to show a positive outlook, primarily propelled by the increasing burden of heart failure and coronary artery diseases, necessitating global mechanical circulatory support. The market has experienced significant growth due to continuous technological advancements, enabling the development of compact and durable ventricular assist devices, fostering market expansion.US heart pump industry to grow at 20.7% CAGR, reaching US$ 4.5 Billion by 2034. Aging population & health concerns drive demand. LVADs lead innovation
NEWARK, Del, Feb. 14, 2024 (GLOBE NEWSWIRE) -- According to Future Market Insights (FMI), the global heart pump device market is expected to grow from *US$ 4.0 billion* in 2024 to* US$ 25.4 billion* by 2034. By 2034, the market is projected to surge at *20.4% *CAGR.The market for heart pump devices is anticipated to expand due to a rising number of people being diagnosed with cardiovascular diseases (CVDs), a growing number of product approvals, and a promising pipeline of new products. The increasing research and development efforts related to heart pump devices are set to positively impact the market's growth.
*Request A Sample Copy of This Report:* https://www.futuremarketinsights.com/reports/sample/rep-gb-18987
Leading companies are considering joint ventures, partnerships, and collaborations to push the development of heart pump technologies. Heart pump devices are set to become significantly more necessary as heart attacks and other cardiac diseases become increasingly common. Due to the growing use of new medical technology, the market for heart pump devices is expected to see increased competition among the leading players.
· According to a National Library of Medicine article, by 2030, around 8 million people in the United States will have heart failure.Due to the increasing incidence of heart failure, the market for heart pump devices is expanding significantly.
*Key Takeaways from the Heart Pump Device Market Report:*
· The heart pump device market is expected to reach a valuation of *US$ 25.4 billion* by 2034.
· The market is projected to surge at a CAGR of *20.4%* by 2034.
· China's heart pump device market is expected to grow at a CAGR of *21.7%* by 2034.
· The United States is projected to reach a valuation of *US$ 4.5 billion* in 2034.
· Based on type, the implanted heart pump devices segment is expected to surge at *20.0%* CAGR by 2034. *"Several governments have been putting measures into place to promote healthcare innovation and hasten the creation & marketing of medical equipment. This includes programs to assist home-grown medical device producers, offer financial incentives for research & development, and streamline regulatory procedures." *– *opines *Sabyasachi Ghosh* Associate Vice President at Future Market Insights (FMI).*
*Request a Methodology: *https://www.futuremarketinsights.com/request-report-methodology/rep-gb-18987
*Competitive Landscape:*
Abbott, ABIOMED, CorWave SA, LivaNova PLC, and Berlin Heart are key heart pump device manufacturers listed in the report. Collaboration between medical device companies, research institutions, and healthcare providers is becoming increasingly common. These partnerships facilitate the exchange of knowledge and resources, accelerating the development and adoption of innovative heart pump devices.
Key firms are pursuing strategic initiatives to optimize their market domination, such as acquisitions, mergers, and collaborations. At the same time, they are introducing cutting-edge products at competitive rates.
*For instance,*
· *In December 2022,* Johnson & Johnson acquired Abiomed, Inc. It is expected to operate independently within Johnson & Johnson's MedTech segment.
· *In 2022,* Abiomed declared that the FDA had approved two clinical research projects involving Impella heart pumps in individuals suffering from acute myocardial infarction (AMI) and cardiogenic shock.
*Key Companies Profiled:*
· Abbott
· ABIOMED
· CorWave SA
· LivaNova PLC
· Berlin Heart
· SynCardia Systems
· LLC
· Jarvik Heart
· BiVACOR Inc.*Buy Now: **https://www.futuremarketinsights.com/checkout/18987*
*Heart Pump Device Market Segmentation by Category:*
*By Type:*
· Implanted Heart Pump Devices
· Extracorporeal Heart Pump Devices
*By Product:*
· Ventricular Assist Devices (VADs)
· Left Ventricular Assist Devices (LVAD)
· Right Ventricular Assist Devices (RVAD)
· Bi-ventricular Assist Devices (BiVAD)
· Percutaneous Ventricular Assist Devices (PVAD)
· Total Artificial Hearts (TAHs)
· Intra-aortic Balloon Pumps (IABPs)
· Extracorporeal Membrane Oxygenation (ECMO)
*By End-use:*
· Hospitals
· Cardiac Centers
· Others*By Region:*
· North America
· Latin America
· Europe
· East Asia
· South Asia
· Oceania
· Middle East and Africa
*Author By:*
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
*Explore FMI’s related ongoing Coverage on **Healthcare Market Insights** Domain:*
· Portable Medical Devices Market Size: The global portable medical devices market is projected to expand at a CAGR of 10.7% during the forecast period. The market is estimated to generate market revenue of US$ 163.84 billion by 2033, increasing from US$ 59.28 billion in 2023.
· Cardiovascular Needle Market Share: The global cardiovascular needle market was valued at around US$ 85.2 Million at the end of 2021. The market is projected to register a 7.5% CAGR and top a valuation of US$ 188.4 Million by 2032.
· Orthopedic Braces and Support Market Demand: The global orthopedic braces and support market is assessed to surpass a valuation of US$ 4.6 billion by 2024 and is projected to reach a value of US$ 8.8 billion by 2034, reflecting a CAGR of 6.7% over the assessment period.
· Needle-Free Injection System Market Growth: The global needle-free injection system market is predicted to grow to US$ 667 million by 2034 from US$ 158 million in 2024. The market is expected to increase at an astounding 15.5% compound annual growth rate between 2024 and 2034.
· ePrescibing Market Trends: The ePrescibing market is expected to grow at a CAGR of 27.1% during the projected period. The market value is projected to increase from US$ 4.8 billion in 2024 to US$ 52.2 billion by 2034.
· Pharmaceutical Manufacturing Equipment Market Overview: The global pharmaceutical manufacturing equipment market is expected to rise at a CAGR of 6.4% during the projected period. The market value is projected to increase from US$ 14.7 billion in 2024 to US$ 27.3 billion by 2034.
· Medical Exoskeleton Market Outlook: The medical exoskeleton market value is estimated to be US$ 394.3 million in 2024. Global population aging is on the rise, creating a greater need for assistive exoskeleton devices for regular activities or rehabilitation. The market is predicted to rise at a robust CAGR of 29.1% during the forecast period. The global medical exoskeleton industry's share is estimated to reach a value of nearly US$ 5,100 million by 2034.
· Medical Display Market Development: The global medical display market size is anticipated to be worth US$ 4.3 billion by 2034. According to the estimates, the market is projected to clock a 5.3% CAGR until 2034. In 2024, the medical display market size is valued at US$ 2.6 billion.
· Veterinary Telemedicine Market Opportunity: The veterinary telemedicine market is estimated to reach a valuation of US$ 145 million in 2024. It is projected to reach a value of US$ 746 million by 2034, reflecting a CAGR of 17.8% over the assessment period
· Cardiology Information System Market Forecast: The cardiology information system market is estimated to be valued at US$ 1.3 billion in 2024. The cardiology information system is predicted to rise at a CAGR of 9.7% from 2024 to 2034. The global cardiology information system market is anticipated to reach US$ 3.7 billion by 2034.
*About Future Market Insights (FMI) *
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
*Contact Us: *
Nandini Singh Sawlani* *
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
*For Sales Enquiries: *sales@futuremarketinsights.com
*Website:* https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube